tiprankstipranks
Acorda Therapeutics (ACOR)
NASDAQ:ACOR

Acorda Therapeutics (ACOR) Cash flow

595 Followers

Acorda Therapeutics Cash Flow

ACOR's free cash flow for Q3 2023 was $7.39M. For the 2023 fiscal year, ACOR's free cash flow was decreased by $20.48M and operating cash flow was $7.61M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -1.90M$ -20.88M$ -41.35M$ -61.01M$ -128.17M$ 150.79M
Investing Cash Flow
$ -97.00K$ -136.00K$ 73.78M$ 59.36M$ -505.00K$ -176.87M
Financing Cash Flow
--$ -69.66M$ -1.67M$ -60.55M$ 12.80M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 141.84M$ 44.72M$ 65.22M$ 102.89M$ 105.19M$ 294.35M
Income Tax Paid Supplemental Data
$ 854.00K$ 199.00K$ 50.00K$ 251.00K$ 2.79M$ 20.71M
Interest Paid Supplemental Data
$ 12.42M$ 7.16M$ 6.00K$ 6.67M$ 6.06M$ 6.06M
Issuance Of Capital Stock
---$ 0.00$ 24.00K$ 15.20M
Issuance Of Debt
--$ -69.66M---
Repayment Of Debt
--$ -69.66M$ -597.00K$ -55.81M$ -657.00K
Free Cash Flow
$ -2.00M$ -21.06M$ -41.54M$ -65.40M$ -218.59M$ 116.88M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Acorda Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis